Roivant Retained Earnings vs Non Currrent Assets Other Analysis

ROIV Stock

USD 11.41 0.09 0.78%

Roivant Sciences financial indicator trend analysis is much more than just breaking down Roivant Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Roivant Sciences is a good investment. Please check the relationship between Roivant Sciences Retained Earnings and its Non Currrent Assets Other accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Retained Earnings vs Non Currrent Assets Other

Retained Earnings vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Roivant Sciences Retained Earnings account and Non Currrent Assets Other. At this time, the significance of the direction appears to have pay attention.

The correlation between Roivant Sciences' Retained Earnings and Non Currrent Assets Other is -0.78. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Roivant Sciences, assuming nothing else is changed. The correlation between historical values of Roivant Sciences' Retained Earnings and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Roivant Sciences are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Retained Earnings i.e., Roivant Sciences' Retained Earnings and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

-0.78

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Roivant Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Roivant Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.At this time, Roivant Sciences' Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to climb to about 3.8 B in 2024, whereas Discontinued Operations is likely to drop slightly above 97.9 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	46.3M	48.2M	55.4M	40.6M
Total Revenue	55.3M	61.3M	70.5M	46.3M

Gross Profit Total Revenue

Roivant Sciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment
Total Assets		0.77	-0.79	0.1	0.99	-0.94	0.87	0.99	0.63	-0.84	-0.34	0.86	0.98	0.85	0.56	0.64	0.98	0.63	0.72	0.76	-0.97	0.8	0.63	0.98	0.4	0.85
Short Long Term Debt Total	0.77		-0.84	0.63	0.68	-0.8	0.36	0.86	0.86	-0.37	-0.73	0.95	0.65	0.98	0.91	0.38	0.66	0.81	0.93	1.0	-0.64	0.98	0.97	0.65	0.74	0.48
Other Current Liab	-0.79	-0.84		-0.27	-0.76	0.73	-0.53	-0.83	-0.91	0.45	0.62	-0.79	-0.73	-0.82	-0.6	-0.64	-0.73	-0.9	-0.78	-0.86	0.73	-0.82	-0.74	-0.72	-0.77	-0.59
Total Current Liabilities	0.1	0.63	-0.27		-0.06	-0.28	-0.38	0.21	0.59	0.38	-0.77	0.51	-0.08	0.58	0.87	-0.38	-0.08	0.53	0.56	0.63	0.1	0.6	0.8	-0.07	0.7	-0.17
Total Stockholder Equity	0.99	0.68	-0.76	-0.06		-0.9	0.92	0.96	0.54	-0.9	-0.23	0.79	1.0	0.77	0.41	0.69	1.0	0.54	0.66	0.67	-0.99	0.72	0.51	0.99	0.29	0.86
Other Liab	-0.94	-0.8	0.73	-0.28	-0.9		-0.74	-0.94	-0.69	0.7	0.55	-0.91	-0.89	-0.88	-0.66	-0.36	-0.9	-0.64	-0.8	-0.77	0.87	-0.86	-0.7	-0.9	-0.49	-0.69
Net Tangible Assets	0.87	0.36	-0.53	-0.38	0.92	-0.74		0.78	0.26	-0.96	0.1	0.5	0.94	0.48	0.09	0.71	0.94	0.3	0.32	0.34	-0.94	0.4	0.16	0.94	0.0	0.9
Property Plant And Equipment Net	0.99	0.86	-0.83	0.21	0.96	-0.94	0.78		0.69	-0.78	-0.44	0.92	0.95	0.91	0.65	0.62	0.95	0.68	0.81	0.85	-0.94	0.87	0.73	0.94	0.47	0.79
Current Deferred Revenue	0.63	0.86	-0.91	0.59	0.54	-0.69	0.26	0.69		-0.14	-0.84	0.77	0.52	0.82	0.78	0.3	0.52	0.98	0.77	0.87	-0.51	0.83	0.85	0.52	0.96	0.4
Net Debt	-0.84	-0.37	0.45	0.38	-0.9	0.7	-0.96	-0.78	-0.14		-0.16	-0.52	-0.91	-0.48	-0.1	-0.72	-0.91	-0.16	-0.34	-0.34	0.92	-0.4	-0.16	-0.91	0.14	-0.86
Retained Earnings	-0.34	-0.73	0.62	-0.77	-0.23	0.55	0.1	-0.44	-0.84	-0.16		-0.7	-0.19	-0.69	-0.78	0.18	-0.2	-0.74	-0.77	-0.73	0.16	-0.76	-0.81	-0.19	-0.88	0.05
Accounts Payable	0.86	0.95	-0.79	0.51	0.79	-0.91	0.5	0.92	0.77	-0.52	-0.7		0.76	0.98	0.83	0.33	0.76	0.7	0.96	0.94	-0.73	0.99	0.9	0.75	0.62	0.51
Cash	0.98	0.65	-0.73	-0.08	1.0	-0.89	0.94	0.95	0.52	-0.91	-0.19	0.76		0.74	0.4	0.7	1.0	0.53	0.61	0.64	-1.0	0.68	0.48	1.0	0.27	0.9
Non Current Assets Total	0.85	0.98	-0.82	0.58	0.77	-0.88	0.48	0.91	0.82	-0.48	-0.69	0.98	0.74		0.89	0.38	0.75	0.78	0.93	0.98	-0.73	0.98	0.94	0.74	0.68	0.56
Non Currrent Assets Other	0.56	0.91	-0.6	0.87	0.41	-0.66	0.09	0.65	0.78	-0.1	-0.78	0.83	0.4	0.89		0.03	0.4	0.73	0.8	0.9	-0.38	0.87	0.97	0.4	0.75	0.29
Other Assets	0.64	0.38	-0.64	-0.38	0.69	-0.36	0.71	0.62	0.3	-0.72	0.18	0.33	0.7	0.38	0.03		0.7	0.39	0.24	0.39	-0.74	0.3	0.18	0.68	0.09	0.78
Cash And Short Term Investments	0.98	0.66	-0.73	-0.08	1.0	-0.9	0.94	0.95	0.52	-0.91	-0.2	0.76	1.0	0.75	0.4	0.7		0.53	0.61	0.64	-1.0	0.69	0.49	1.0	0.27	0.89
Net Receivables	0.63	0.81	-0.9	0.53	0.54	-0.64	0.3	0.68	0.98	-0.16	-0.74	0.7	0.53	0.78	0.73	0.39	0.53		0.68	0.83	-0.52	0.76	0.8	0.53	0.94	0.48
Common Stock Shares Outstanding	0.72	0.93	-0.78	0.56	0.66	-0.8	0.32	0.81	0.77	-0.34	-0.77	0.96	0.61	0.93	0.8	0.24	0.61	0.68		0.93	-0.58	0.98	0.9	0.6	0.66	0.29
Non Current Liabilities Total	0.76	1.0	-0.86	0.63	0.67	-0.77	0.34	0.85	0.87	-0.34	-0.73	0.94	0.64	0.98	0.9	0.39	0.64	0.83	0.93		-0.63	0.97	0.97	0.63	0.77	0.47
Other Current Assets	-0.97	-0.64	0.73	0.1	-0.99	0.87	-0.94	-0.94	-0.51	0.92	0.16	-0.73	-1.0	-0.73	-0.38	-0.74	-1.0	-0.52	-0.58	-0.63		-0.66	-0.46	-0.99	-0.25	-0.92
Other Stockholder Equity	0.8	0.98	-0.82	0.6	0.72	-0.86	0.4	0.87	0.83	-0.4	-0.76	0.99	0.68	0.98	0.87	0.3	0.69	0.76	0.98	0.97	-0.66		0.95	0.68	0.71	0.44
Total Liab	0.63	0.97	-0.74	0.8	0.51	-0.7	0.16	0.73	0.85	-0.16	-0.81	0.9	0.48	0.94	0.97	0.18	0.49	0.8	0.9	0.97	-0.46	0.95		0.48	0.8	0.31
Total Current Assets	0.98	0.65	-0.72	-0.07	0.99	-0.9	0.94	0.94	0.52	-0.91	-0.19	0.75	1.0	0.74	0.4	0.68	1.0	0.53	0.6	0.63	-0.99	0.68	0.48		0.27	0.9
Short Term Debt	0.4	0.74	-0.77	0.7	0.29	-0.49	0.0	0.47	0.96	0.14	-0.88	0.62	0.27	0.68	0.75	0.09	0.27	0.94	0.66	0.77	-0.25	0.71	0.8	0.27		0.17
Property Plant Equipment	0.85	0.48	-0.59	-0.17	0.86	-0.69	0.9	0.79	0.4	-0.86	0.05	0.51	0.9	0.56	0.29	0.78	0.89	0.48	0.29	0.47	-0.92	0.44	0.31	0.9	0.17

Click cells to compare fundamentals

Roivant Sciences Account Relationship Matchups

Roivant Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.5B	2.6B	2.6B	2.4B	2.7B	2.5B
Short Long Term Debt Total	180.9M	245.0M	283.9M	481.4M	553.6M	293.6M
Other Current Liab	70.4M	180.2M	128.2M	15.1M	13.6M	12.9M
Total Current Liabilities	92.1M	219.0M	184.4M	272.4M	313.3M	215.4M
Total Stockholder Equity	2.0B	1.8B	2.0B	1.6B	1.8B	1.8B
Other Liab	103.2M	76.1M	66.8M	80.6M	72.5M	71.0M
Net Tangible Assets	2.0B	1.8B	1.7B	1.0B	1.2B	1.6B
Property Plant And Equipment Net	73.9M	77.0M	86.9M	92.3M	106.2M	75.1M
Current Deferred Revenue	3.6M	5.9M	10.1M	167.1M	192.2M	201.8M
Net Debt	(2.0B)	(1.8B)	(1.8B)	(1.2B)	(1.1B)	(1.1B)
Retained Earnings	(1.1B)	(1.9B)	(2.8B)	(3.8B)	(3.4B)	(3.6B)
Accounts Payable	10.3M	20.6M	34.6M	37.8M	43.5M	24.1M
Cash	2.2B	2.1B	2.1B	1.7B	1.9B	1.9B
Non Current Assets Total	257.8M	402.7M	438.6M	591.0M	679.7M	416.3M
Non Currrent Assets Other	6.7M	36.1M	25.8M	49.5M	56.9M	30.7M
Other Assets	90.4M	36.1M	25.8M	49.5M	44.5M	35.9M
Cash And Short Term Investments	2.2B	2.1B	2.1B	1.7B	1.9B	1.9B
Net Receivables	15.3M	13.8M	6.7M	32.7M	37.6M	39.5M
Liabilities And Stockholders Equity	2.5B	2.6B	2.6B	2.4B	2.7B	2.5B
Non Current Liabilities Total	276.2M	308.7M	339.3M	509.6M	586.0M	368.1M
Other Current Assets	18.5M	54.3M	82.2M	121.8M	109.6M	96.3M
Other Stockholder Equity	3.1B	3.7B	4.8B	5.4B	6.2B	4.4B
Total Liab	368.4M	527.7M	546.2M	782.0M	899.3M	588.4M
Total Current Assets	2.2B	2.2B	2.1B	1.8B	2.1B	2.1B
Accumulated Other Comprehensive Income	(2.3M)	1.4M	(946K)	(2.6M)	(2.4M)	(2.2M)
Short Term Debt	7.8M	12.3M	11.4M	52.4M	60.3M	63.3M
Property Plant Equipment	73.9M	77.0M	25.9M	39.1M	44.9M	50.0M

When determining whether Roivant Sciences is a strong investment it is important to analyze Roivant Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Roivant Sciences' future performance. For an informed investment choice regarding Roivant Stock, refer to the following important reports:

How To Invest In Roivant

Details

Is Roivant Stock a good investment?

Details

What is Roivant Sciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Roivant Stock analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

5.27

Revenue Per Share

0.16

Quarterly Revenue Growth

1.178

Return On Assets

(0.14)

Return On Equity

1.058

The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Roivant Retained Earnings vs Non Currrent Assets Other Analysis

Retained Earnings vs Non Currrent Assets Other

Retained Earnings vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Retained Earnings

Non Currrent Assets Other

Roivant Sciences fundamental ratios Correlations

Roivant Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Roivant Sciences fundamental ratios Accounts

Complementary Tools for Roivant Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Other Current Assets	- 1.0	Cash And Short Term Investments
Other Current Assets	- 1.0	Cash
Total Current Assets	- 0.99	Other Current Assets
Other Current Assets	- 0.99	Total Stockholder Equity
Other Current Assets	- 0.97	Total Assets
Net Debt	- 0.96	Net Tangible Assets